View Older Stories

May 11, 2026 07:02AM AIML appoints cardiac electrophysiology expert to medical advisory board

May 11, 2026 07:00AM AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options

Apr 24, 2026 07:51PM AI/ML Innovations Announces Completion of Share Issuance

Apr 17, 2026 08:00PM AI/ML Innovations Announces Completion of Share Issuance

Mar 31, 2026 07:00AM Neural Cloud signs reseller deal with European cardiac monitoring platform

Mar 31, 2026 07:00AM Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform

Mar 27, 2026 05:00PM AIML closes first tranche of private placement raising $950,000

Mar 27, 2026 05:00PM AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000

Mar 25, 2026 07:00AM AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis

Mar 12, 2026 07:31PM AI/ML Innovations proposes $3 million convertible debenture offering

Mar 12, 2026 07:30PM AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures

Feb 24, 2026 07:30AM Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America

Feb 12, 2026 07:00AM AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

Feb 10, 2026 07:00AM Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion

Jan 28, 2026 07:00AM AIML appoints cardiologist Dr. Paul Dorian to lead medical advisory board

Jan 28, 2026 07:00AM AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board

Jan 8, 2026 07:00AM AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis

Jan 7, 2026 07:02AM AIML appoints Erik Suokas as chief operating officer

Jan 7, 2026 07:00AM AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale

Dec 30, 2025 07:31AM AIML concludes consulting agreement, names CEO as president

Dec 30, 2025 07:30AM AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer

Dec 16, 2025 07:30AM Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy

Dec 9, 2025 07:30AM AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem

Dec 2, 2025 07:30AM AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing

Nov 26, 2025 07:30AM AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms

Nov 24, 2025 07:30AM AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

Nov 11, 2025 07:30AM AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture

Nov 4, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica

Oct 21, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting

Oct 15, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica

Oct 7, 2025 07:00AM AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting

Sep 30, 2025 07:00AM AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection

Sep 22, 2025 08:15PM AIML raises $2.13 million in oversubscribed private placement

Sep 22, 2025 08:15PM AIML Announces Closing of Oversubscribed Private Placement

Sep 4, 2025 08:26AM AIML plans private placement to raise up to $1.55 million

Sep 4, 2025 08:25AM AIML Announces Proposed Private Placement

Aug 21, 2025 05:35PM AIML Announces SEDAR Filing

Aug 8, 2025 05:30PM AIML Innovations Closes Quantum Sciences Ltd. Restructuring

Jun 10, 2025 07:00AM AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing

May 22, 2025 07:00AM AI/ML Establishes Innovation Committee, Appoints Dr. Drew Dundas as Chair

May 15, 2025 07:00AM AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform

May 5, 2025 07:00AM AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors

Apr 25, 2025 05:30PM AIML Innovations Announces Departure of Tim Daniels from Board of Directors

Apr 25, 2025 05:00PM AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus

Apr 22, 2025 07:00AM AIML Innovations Appoints Jared Adelstein to Board of Directors

Apr 15, 2025 05:30PM AIML Announces Closing of Oversubscribed Private Placement

Apr 7, 2025 08:00AM AIML Updates Terms of Proposed Private Placement Announced

Apr 4, 2025 07:00PM AIML Announces Proposed Private Placement

Mar 21, 2025 05:15PM AIML Continues to Streamline for the Future and Moves Beyond Tech2Heal

Mar 14, 2025 07:00AM AIML Aligns Leadership for Growth and Shareholder Value Creation

View Older Stories